The Marginal Liver Donor and Organ Preservation Strategies

  • Abdulrhman S. Elnaggar
  • James V. Guarrera


According to the United Network for Organ Sharing (UNOS) data, 8,082 liver transplants have been performed in 2017 with 14,177 patients on the waiting list as of March 2018 [ 1]. The advances in patient and donor selection, surgical techniques, immunosuppression, organ preservation and critical care management have made lifesaving liver transplantation possible to those with irrevocable liver damage and acute liver failure. Yet the scarcity of organs continues to be a major obstacle to the greater application of liver transplantation (Fig. 17.1).


MELD score Steatosis Donation after cardiac death Donor risk index Organ preservation Ischemia/reperfusion injury 


  1. 1.
  2. 2.
    Emre S, Schwartz ME, Altaca G, Sethi P, Fiel MI, Guy SR, Kelly DM, Sebastian A, Fisher A, Eickmeyer D, Sheiner PA, Miller CM. Safe use of hepatic allografts from donors older than 70 years. Transplantation. 1996;62(1):62–5.CrossRefGoogle Scholar
  3. 3.
  4. 4.
    Oh CK, Sanfey HA, Pelletier SJ, Sawyer RG, McCullough CS, Pruett TL. Implication of advanced donor age on the outcome of liver transplantation. Clin Transplant. 2000;14(4 Pt 2):386–90.CrossRefGoogle Scholar
  5. 5.
    Wall WJ, Mimeault R, Grant DR, Bloch M. The use of older donor livers for hepatic transplantation. Transplantation. 1990;49(2):377–81.CrossRefGoogle Scholar
  6. 6.
    Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, Belle SH, Detre KM. Donor age and outcome of liver transplantation. Hepatology. 1996;24(1):89–96.CrossRefGoogle Scholar
  7. 7.
    Paterno F, Wima K, Hoehn RS, Cuffy MC, Diwan TS, Woodle SE, Abbott DE, Shah SA. Use of elderly allografts in liver transplantation. Transplantation. 2016;100(1):153–8.CrossRefGoogle Scholar
  8. 8.
    Rull R, Vidal O, Momblan D, González FX, López-Boado MA, Fuster J, Grande L, Bruguera M, Cabrer K, García-Valdecasas JC. Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation. Liver Transpl. 2003;9(4):389–93.CrossRefGoogle Scholar
  9. 9.
    Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation. 2007;84(3):331–9.CrossRefGoogle Scholar
  10. 10.
    Mutimer DJ, Gunson B, Chen J, Berenguer J, Neuhaus P, Castaing D, Garcia-Valdecasas JC, Salizzoni M, Moreno GE, Mirza D. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation. 2006;81(1):7–14.CrossRefGoogle Scholar
  11. 11.
    Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation. 2005;80(1):145–8.CrossRefGoogle Scholar
  12. 12.
    Pungpapong S, Aqel BA, Koning L, Murphy JL, Henry TM, Ryland KL, Yataco ML, Satyanarayana R, Rosser BG, Vargas HE, Charlton MR, Keaveny AP. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl. 2013;19(7):690–700.CrossRefGoogle Scholar
  13. 13.
    Coilly A, Roche B, Dumortier J, Leroy V, Botta-Fridlund D, Radenne S, Pageaux GP, Si-Ahmed SN, Guillaud O, Antonini TM, Haïm-Boukobza S, Roque-Afonso AM, Samuel D, Duclos-Vallée JC. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience. J Hepatol. 2014;60(1):78–86.CrossRefGoogle Scholar
  14. 14.
    Coilly A, Dumortier J, Botta-Fridlund D, Latournerie M, Leroy V, Pageaux GP, Agostini H, Giostra E, Moreno C, Roche B, Antonini TM, Guillaud O, Lebray P, Radenne S, Saouli AC, Calmus Y, Alric L, Debette-Gratien M, De Ledinghen V, Durand F, Duvoux C, Samuel D, Duclos-Vallée JC. Multicenter experience with boceprevir or telaprevir to treat hepatitis c recurrence after liver transplantation: when present becomes past, what lessons for future? PLoS One. 2015;10(9):e0138091.CrossRefGoogle Scholar
  15. 15.
    Takeda Y, Arii S, Kaido T, Niwano M, Moriga T, Mori A, Hanaki K, Gorrin-Rivas MJ, Ishii T, Sato M, Imamura M. Morphologic alteration of hepatocytes and sinusoidal endothelial cells in rat fatty liver during cold preservation and the protective effect of hepatocyte growth factor. Transplantation. 1999;67(6):820–8.CrossRefGoogle Scholar
  16. 16.
    Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis. Transplant Proc. 1997;29(1–2):412–5.CrossRefGoogle Scholar
  17. 17.
    Lemasters JJ, Peng XX, Bachmann S, Currin RT, Gao W, Thurman RG. Dual role of Kupffer cell activation and endothelial cell damage in reperfusion injury to livers stored for transplantation surgery. J Gastroenterol Hepatol. 1995;10(Suppl 1):S84–7.CrossRefGoogle Scholar
  18. 18.
    Markin RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, Hirst K, Shaw BW. Frozen section evaluation of donor livers before transplantation. Transplantation. 1993;56(6):1403–9.CrossRefGoogle Scholar
  19. 19.
    Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, Miller CM, Sheiner PA. Use of livers with microvesicular fat safely expands the donor pool. Transplantation. 1997;64(2):248–51.CrossRefGoogle Scholar
  20. 20.
    Trevisani F, Colantoni A, Caraceni P, Van Thiel DH. The use of donor fatty liver for liver transplantation: a challenge or a quagmire? J Hepatol. 1996;24(1):114–21.CrossRefGoogle Scholar
  21. 21.
    Porte RJ, Ploeg RJ, Hansen B, van Bockel JH, Thorogood J, Persijn GG, Hermans J, Terpstra OT. Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicentre Study Group. Transpl Int. 1998;11(Suppl 1):S164–7.CrossRefGoogle Scholar
  22. 22.
    Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, Kalayoglu M. Risk factors for primary dysfunction after liver transplantation—a multivariate analysis. Transplantation. 1993;55(4):807–13.CrossRefGoogle Scholar
  23. 23.
    Scotté M, Dousset B, Calmus Y, Conti F, Houssin D, Chapuis Y. The influence of cold ischemia time on biliary complications following liver transplantation. J Hepatol. 1994;21(3):340–6.CrossRefGoogle Scholar
  24. 24.
    Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342(9):605–12.CrossRefGoogle Scholar
  25. 25.
    Yersiz H, Shaked A, Olthoff K, Imagawa D, Shackleton C, Martin P, Busuttil RW. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation. 1995;60(8):790–4.CrossRefGoogle Scholar
  26. 26.
    Castells L, Vargas V, Rodríguez-Frías F, Allende H, Jardí R, Margarit C, Esteban R, Guardia J. Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Transplant Proc. 1999;31(6):2464–5.CrossRefGoogle Scholar
  27. 27.
    Uemoto S, Inomata Y, Sannomiya A, Koshiba T, Kurokawa T, Takatsuki M, Hino H, Yokoi A, Tanaka K. Posttransplant hepatitis B infection in liver transplantation with hepatitis B core antibody-positive donors. Transplant Proc. 1998;30(1):134–5.CrossRefGoogle Scholar
  28. 28.
    Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F. The risk of transmission of hepatitis B from HBsAg(−), HBcAb(+), HBIgM(−) organ donors. Transplantation. 1995;59(2):230–4.CrossRefGoogle Scholar
  29. 29.
    Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, Zetterman RK, Pruett TL, Ishitani MB, Hoofnagle JH. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology. 1997;113(5):1668–74.CrossRefGoogle Scholar
  30. 30.
    Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, David MF, Arulnaden JL, Bismuth A, Reynes M, Bismuth H. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol. 1997;26(3):517–26.CrossRefGoogle Scholar
  31. 31.
    Dodson SF, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B, Iwatsuki S, Montalvo E, Rakela J, Fung JJ. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation. 1997;64(11):1582–4.CrossRefGoogle Scholar
  32. 32.
    Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H, Kiuchi T, Miyake Y, Tanaka K, Chiba T. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation. 1998;65(4):494–9.CrossRefGoogle Scholar
  33. 33.
    Nery JR, Gedaly R, Vianna R, Berho M, Weppler D, Levi D, Kato T, Khan F, Pinna A, Schiff E, Tzakis A. Are liver grafts from hepatitis B surface antigen negative/anti-hepatitis B core antibody positive donors suitable for transplantation? Transplant Proc. 2001;33(1–2):1521–2.CrossRefGoogle Scholar
  34. 34.
    Joya-Vazquez PP, Dodson FS, Dvorchik I, Gray E, Chesky A, Demetris AJ, Shakil O, Fung JJ, Vargas HE. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation. 2002;73(10):1598–602.CrossRefGoogle Scholar
  35. 35.
    Loss GE, Mason AL, Blazek J, Dick D, Lipscomb J, Guo L, Perrillo RP, Eason JD. Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results. Clin Transplant. 2001;15(Suppl 6):55–8.CrossRefGoogle Scholar
  36. 36.
    Salizzoni M, Lupo F, Zamboni F, Franchello A, Lavezzo B, Cerutti E, Strignano P. Outcome of patients transplanted with liver from hepatitis C positive donors. Transplant Proc. 2001;33(1–2):1507–8.CrossRefGoogle Scholar
  37. 37.
    Velidedeoglu E, Desai NM, Campos L, Olthoff KM, Shaked A, Nunes F, Zeldin G, Stewart C, Blumberg E, Abrams J, Markmann JF. Effect of donor hepatitis C on liver graft survival. Transplant Proc. 2001;33(7–8):3795–6.CrossRefGoogle Scholar
  38. 38.
    Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, Farmer DG, Yersiz H, Danino N, Collisson E, Baquarizo A, Han SS, Saab S, Goldstein LI, Donovan JA, Esrason K, Busuttil RW. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg. 2001;234(3):384–93. discussion 393-4.CrossRefGoogle Scholar
  39. 39.
    Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl. 2003;9(10):1053–61.CrossRefGoogle Scholar
  40. 40.
    Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Ascher NL. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992;103(1):317–22.CrossRefGoogle Scholar
  41. 41.
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996;334(13):815–20.CrossRefGoogle Scholar
  42. 42.
    Verna EC, O'Leary JG. Hepatitis C treatment in patients on the liver transplant waiting list. Curr Opin Organ Transplant. 2015;20(3):242–50.CrossRefGoogle Scholar
  43. 43.
    Burton JR, O'Leary JG, Verna EC, Saxena V, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS, Terrault NA. A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy. J Hepatol. 2014;61(3):508–14.CrossRefGoogle Scholar
  44. 44.
    Verna EC, Saxena V, Burton JR, O'Leary JG, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS, Terrault NA, Consortium C-C. Telaprevir- and boceprevir-based triple therapy for hepatitis C in liver transplant recipients with advanced recurrent disease: a multicenter study. Transplantation. 2015;99(8):1644–51.CrossRefGoogle Scholar
  45. 45.
    Singhal A, Wima K, Hoehn RS, Quillin RC, Woodle ES, Paquette IM, Paterno F, Abbott DE, Shah SA. Hospital resource use with donation after cardiac death allografts in liver transplantation: a matched controlled analysis from 2007 to 2011. J Am Coll Surg. 2015;220(5):951–8.CrossRefGoogle Scholar
  46. 46.
    Selck FW, Grossman EB, Ratner LE, Renz JF. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg. 2008;248(4):599–607.PubMedGoogle Scholar
  47. 47.
    Yamamoto S, Wilczek HE, Duraj FF, Groth CG, Ericzon BG. Liver transplantation with grafts from controlled donors after cardiac death: a 20-year follow-up at a single center. Am J Transplant. 2010;10(3):602–11.CrossRefGoogle Scholar
  48. 48.
    Pine JK, Aldouri A, Young AL, Davies MH, Attia M, Toogood GJ, Pollard SG, Lodge JP, Prasad KR. Liver transplantation following donation after cardiac death: an analysis using matched pairs. Liver Transpl. 2009;15(9):1072–82.CrossRefGoogle Scholar
  49. 49.
    Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, Rosser BG, Keaveny AP, Aranda-Michel J, Satyanarayana R, Harnois D, Dickson RC, Kramer DJ, Hughes CB. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009;15(9):1028–35.CrossRefGoogle Scholar
  50. 50.
    Skaro AI, Jay CL, Baker TB, Wang E, Pasricha S, Lyuksemburg V, Martin JA, Feinglass JM, Preczewski LB, Abecassis MM. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery. 2009;146(4):543–52. discussion 552-3.CrossRefGoogle Scholar
  51. 51.
    Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation. 2003;75(10):1659–63.CrossRefGoogle Scholar
  52. 52.
    Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010;10(11):2512–9.CrossRefGoogle Scholar
  53. 53.
    Scalea JR, Redfield RR, Foley DP. Liver transplant outcomes using ideal donation after circulatory death livers are superior to using older donation after brain death donor livers. Liver Transpl. 2016;22(9):1197–204.CrossRefGoogle Scholar
  54. 54.
    Lazzeri C, Bonizzoli M, Valente S, Cianchi G, Migliaccio ML, Gensini GF, Peris A. The role of extracorporeal membrane oxygenation in donation after circulatory death. Minerva Anestesiol. 2014;80(11):1217–27.PubMedGoogle Scholar
  55. 55.
    Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6(4):783–90.CrossRefGoogle Scholar
  56. 56.
    Green M, Covington S, Taranto S, Wolfe C, Bell W, Biggins SW, Conti D, DeStefano GD, Dominguez E, Ennis D, Gross T, Klassen-Fischer M, Kotton C, LaPointe-Rudow D, Law Y, Ludrosky K, Menegus M, Morris MI, Nalesnik MA, Pavlakis M, Pruett T, Sifri C, Kaul D. Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. Transplantation. 2015;99(2):282–7.CrossRefGoogle Scholar
  57. 57.
    Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL. Transplant tumor registry: donors with central nervous system tumors1. Transplantation. 2002;73(4):579–82.CrossRefGoogle Scholar
  58. 58.
    Myron Kauffman H, McBride MA, Cherikh WS, Spain PC, Marks WH, Roza AM. Transplant tumor registry: donor related malignancies. Transplantation. 2002;74(3):358–62.CrossRefGoogle Scholar
  59. 59.
    Nalesnik MA, Woodle ES, Dimaio JM, Vasudev B, Teperman LW, Covington S, Taranto S, Gockerman JP, Shapiro R, Sharma V, Swinnen LJ, Yoshida A, Ison MG. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant. 2011;11(6):1140–7.CrossRefGoogle Scholar
  60. 60.
    Alkofer B, Samstein B, Guarrera JV, Kin C, Jan D, Bellemare S, Kinkhabwala M, Brown R, Emond JC, Renz JF. Extended-donor criteria liver allografts. Semin Liver Dis. 2006;26(3):221–33.CrossRefGoogle Scholar
  61. 61.
    Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, Kam I, Pruett TL, Everhart JE, Hulbert-Shearon TE, Gillespie BW, Emond JC, Group AAS. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005;242(3):314–23. discussion 323-5.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Hong JC, Yersiz H, Busuttil RW. Where are we today in split liver transplantation? Curr Opin Organ Transplant. 2011;16(3):269–73.CrossRefGoogle Scholar
  63. 63.
    Trotter JF, Gillespie BW, Terrault NA, Abecassis MM, Merion RM, Brown RS, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE, Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2011;17(4):409–17.CrossRefGoogle Scholar
  64. 64.
    Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284(1):G15–26.CrossRefGoogle Scholar
  65. 65.
    Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology. 1998;27(6):1652–60.CrossRefGoogle Scholar
  66. 66.
    Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology. 1991;13(1):83–95.PubMedGoogle Scholar
  67. 67.
    Vajdová K, Smreková R, Kukan M, Lutterová M, Wsólová L. Bile analysis as a tool for assessing integrity of biliary epithelial cells after cold ischemia—reperfusion of rat livers. Cryobiology. 2000;41(2):145–52.CrossRefGoogle Scholar
  68. 68.
    Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation. 1992;53(5):957–78.CrossRefGoogle Scholar
  69. 69.
    Kupiec-Weglinski JW, Busuttil RW. Ischemia and reperfusion injury in liver transplantation. Transplant Proc. 2005;37(4):1653–6.CrossRefGoogle Scholar
  70. 70.
    Jaeschke H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact. 1991;79(2):115–36.CrossRefGoogle Scholar
  71. 71.
    Atalla SL, Toledo-Pereyra LH, MacKenzie GH, Cederna JP. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation. 1985;40(6):584–90.CrossRefGoogle Scholar
  72. 72.
    Menger MD. Microcirculatory disturbances secondary to ischemia-reperfusion. Transplant Proc. 1995;27(5):2863–5.PubMedGoogle Scholar
  73. 73.
    McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312(3):159–63.CrossRefGoogle Scholar
  74. 74.
    Momii S, Koga A. Time-related morphological changes in cold-stored rat livers. A comparison of Euro-Collins solution with UW solution. Transplantation. 1990;50(5):745–50.CrossRefGoogle Scholar
  75. 75.
    Gebhard MM, Bretschneider HJ, Gersing E, Preusse CJ, Schnabel PA, Ulbricht LJ. Calcium-free cardioplegia—pro. Eur Heart J. 1983;4(Suppl H):151–60.CrossRefGoogle Scholar
  76. 76.
    Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988;45(4):673–6.CrossRefGoogle Scholar
  77. 77.
    Menasché P, Termignon JL, Pradier F, Grousset C, Mouas C, Alberici G, Weiss M, Piwnica A, Bloch G. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg. 1994;8(4):207–13.CrossRefGoogle Scholar
  78. 78.
    Bessems M, Doorschodt BM, van Vliet AK, van Gulik TM. Machine perfusion preservation of the non-heart-beating donor rat livers using polysol, a new preservation solution. Transplant Proc. 2005;37(1):326–8.CrossRefGoogle Scholar
  79. 79.
    Guarrera JV, Henry SD, Samstein B, Odeh-Ramadan R, Kinkhabwala M, Goldstein MJ, Ratner LE, Renz JF, Lee HT, Brown RS, Emond JC. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant. 2010;10(2):372–81.CrossRefGoogle Scholar
  80. 80.
    Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, Napieralski BP, van Kasterop-Kutz M, van der Heide JJ, Squifflet JP, van Heurn E, Kirste GR, Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med. 2009;360(1):7–19.CrossRefGoogle Scholar
  81. 81.
    Lee CY, Zhang JX, Jones JW, Southard JH, Clemens MG. Functional recovery of preserved livers following warm ischemia: improvement by machine perfusion preservation. Transplantation. 2002;74(7):944–51.CrossRefGoogle Scholar
  82. 82.
    Iwamoto H, Matsuno N, Narumi Y, Uchiyama M, Kozaki K, Degawa H, Hama K, Kikuchi K, Takeuchi H, Kozaki M, Nagao T. Beneficial effect of machine perfusion preservation on liver transplantation from non-heart-beating donors. Transplant Proc. 2000;32(7):1645–6.CrossRefGoogle Scholar
  83. 83.
    Guarrera JV, Henry SD, Chen SW, Brown T, Nachber E, Arrington B, Boykin J, Samstein B, Brown RS, Emond JC, Lee HT. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results. J Surg Res. 2011;167(2):e365–73.CrossRefGoogle Scholar
  84. 84.
    Guarrera JV, Henry SD, Samstein B, Reznik E, Musat C, Lukose TI, Ratner LE, Brown RS, Kato T, Emond JC. Hypothermic machine preservation facilitates successful transplantation of “orphan” extended criteria donor livers. Am J Transplant. 2015;15(1):161–9.CrossRefGoogle Scholar
  85. 85.
    Dutkowski P, Schlegel A, de Oliveira M, Müllhaupt B, Neff F, Clavien PA. HOPE for human liver grafts obtained from donors after cardiac death. J Hepatol. 2014;60(4):765–72.CrossRefGoogle Scholar
  86. 86.
    Dutkowski P, Polak WG, Muiesan P, Schlegel A, Verhoeven CJ, Scalera I, DeOliveira ML, Kron P, Clavien PA. First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants: an international-matched case analysis. Ann Surg. 2015;262(5):764–70. discussion 770-1.CrossRefGoogle Scholar
  87. 87.
    Karangwa SA, Dutkowski P, Fontes P, Friend PJ, Guarrera JV, Markmann JF, Mergental H, Minor T, Quintini C, Selzner M, Uygun K, Watson CJ, Porte RJ. Machine perfusion of donor livers for transplantation: a proposal for standardized nomenclature and reporting guidelines. Am J Transplant. 2016;16:2932–42.CrossRefGoogle Scholar
  88. 88.
    Ravikumar R, Jassem W, Mergental H, Heaton N, Mirza D, Perera MT, Quaglia A, Holroyd D, Vogel T, Coussios CC, Friend PJ. Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial. Am J Transplant. 2016;16(6):1779–87.CrossRefGoogle Scholar
  89. 89.
    Mergental H, Perera MT, Laing RW, Muiesan P, Isaac JR, Smith A, Stephenson BT, Cilliers H, Neil DA, Hübscher SG, Afford SC, Mirza DF. Transplantation of declined liver allografts following normothermic ex-situ evaluation. Am J Transplant. 2016;16:3235–45.CrossRefGoogle Scholar
  90. 90.
    Watson CJ, Kosmoliaptsis V, Randle LV, Russell NK, Griffiths WJ, Davies S, Mergental H, Butler AJ. Preimplant normothermic liver perfusion of a suboptimal liver donated after circulatory death. Am J Transplant. 2016;16(1):353–7.CrossRefGoogle Scholar
  91. 91.
    Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, Katori M, Volk HD, Busuttil RW, Buelow R, Kupiec-Weglinski JW. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology. 2002;35(4):815–23.CrossRefGoogle Scholar
  92. 92.
    Kaizu T, Nakao A, Tsung A, Toyokawa H, Sahai R, Geller DA, Murase N. Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery. 2005;138(2):229–35.CrossRefGoogle Scholar
  93. 93.
    de Rougemont O, Lehmann K, Clavien PA. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl. 2009;15(10):1172–82.CrossRefGoogle Scholar
  94. 94.
    Lehmann TG, Wheeler MD, Froh M, Schwabe RF, Bunzendahl H, Samulski RJ, Lemasters JJ, Brenner DA, Thurman RG. Effects of three superoxide dismutase genes delivered with an adenovirus on graft function after transplantation of fatty livers in the rat. Transplantation. 2003;76(1):28–37.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of SurgeryColumbia University Medical CenterNew YorkUSA
  2. 2.Division of Liver Transplant and Hepatobiliary SurgeryRutgers New Jersey Medical School, University HospitalNew YorkUSA

Personalised recommendations